Robert F. Kennedy Jr.'s overhaul of a pivotal federal health advisory panel has frozen a potential update on helping children quit smoking, according to a former member of the group who recently left the committee.
The US Preventive Services Task Force, created during the Reagan administration and woven into the Affordable Care Act's insurance coverage framework, has not held a binding vote since March 2025. The Trump administration postponed or canceled all meetings of the panel, effectively halting progress on 14 separate health topics, including cervical cancer screening, perinatal depression, and autism screening.
Dr. Michael Silverstein, who served on the taskforce until he rotated off in March, said the panel was preparing to evaluate promising new evidence on youth tobacco cessation. "There was a lot of new, very encouraging evidence on tobacco cessation for kids," Silverstein said. "We're talking about children and tobacco. I can't imagine there's anything controversial about that."
Without formal group meetings, the taskforce never reached a draft recommendation on the updated evidence, leaving the potential guidance in limbo.
Kennedy's operations have been aggressive. He fired two taskforce leaders in May and, during April congressional testimony, labeled the panel's members "lackadaisical and negligent for 20 years." The Department of Health and Human Services attributed the meeting freeze to an unusually high volume of membership nominations that needed processing.
The timing coincides with a broader administration rollback of tobacco control efforts. The CDC's office on smoking and health shuttered over a year ago. The "Tips from Former Smokers" campaign, which aired graphic warnings featuring a smoker whose teeth and jaw were removed due to oral cancer, ended last year. The FDA's lead tobacco regulator was removed in April 2025.
The upheaval extends beyond smoking. Dr. Marty Makary, a former Trump FDA commissioner, resigned in protest after the agency adopted a new policy allowing tobacco companies to sell flavored vapes. The policy reversal followed a $5 million donation from a Reynolds American subsidiary to a Trump-backed Super PAC.
The ability to reshape the taskforce rests on fresh legal ground. In 2025, the Supreme Court clarified that Kennedy holds appointment and removal power over the panel's members. That decision stemmed from a case challenging the taskforce's recommendation that insurance cover pre-exposure prophylaxis, or PrEP, for HIV prevention. Conservative medical groups, including the Association of American Physicians and Surgeons, had argued the medication was designed for "risky lifestyles."
Silverstein stressed that delays are rippling across critical public health domains. "The inability to meet has also caused recommendations on perinatal depression and cervical cancer screening to be delayed, issues with very, very important public health implications," he said.
Outside observers are frustrated by the opacity. Dr. Aaron E. Carroll, president of AcademyHealth, a nonpartisan health policy research group, said the lack of transparency breaks with historical norms. "Republican and Democratic administrations, including the previous Trump administration, were not like this. The fact we can't get answers to the most basic of questions after a full year is staggering," Carroll said.
The vacuum has created an opening for industry. Politico reported that device and test manufacturers have begun lobbying the taskforce's supporting agency. Guardant Health, which manufactures a blood test for colorectal cancer, spent $241,000 lobbying the Agency for Healthcare Quality and Research in the first quarter of 2026 and launched a public petition urging Kennedy to update colon cancer screening guidelines.
Kennedy has offered minimal guidance about his vision for the taskforce beyond a casual mention of increased Alzheimer's screening during his April testimony. The HHS declined to clarify the secretary's priorities when asked.
Carroll summed up the climate: "It's somewhat humorous, but also sad, that we have to keep guessing what is going on in our government instead of actually knowing."
Author James Rodriguez: "A year without formal votes on critical health recommendations is not a delay, it's a standstill, and the public deserves to know why."
Comments